ArticleUpdates in surgery2026
Surgical management of pancreatic neck cancer: an ongoing dilemma.
Article in Updates in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Splenic hilum nodal involvement in resected left-sided pancreatic cancer: meta-analysis.BJS open · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The surgical management of pancreatic neck adenocarcinoma (neck PDAC) ranges from extended pancreaticoduodenectomy (ePD) to subtotal left pancreatectomy (sLP) and total pancreatectomy, with no clear consensus on the optimal approach. This study aimed to compare ePD and sLP in terms of perioperative and long-term outcomes. All patients who underwent ePD or sLP for neck PDAC were retrospectively reviewed and compared for perioperative and long-term outcomes. Forty-six patients were included: 18 (39.1%) underwent ePD and 28 (60.9%) sLP. ePD was associated with a higher rate of neoadjuvant treatment, longer operative time, and longer hospital stay. The most frequently involved lymph-node stations were #13-17 in the ePD group (44.4%) and #18 in the sLP group (42.9%). Overall survival (OS) was similar (p = 0.06), while disease-free survival (DFS) was longer in the sLP group (16 [9-22] vs 12 [5-18] months in the ePD group; p = 0.03). Due to the high rate of nodal metastases in station #13-17 and #18, both procedures may be inadequate as surgical treatment of neck PDAC. While sLP appears to offer better long-term outcomes, the heterogeneity of the study population limits generalizability. Larger prospective studies are needed to determine the most effective surgical approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.